These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7835785)

  • 1. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature.
    Cohen I; Altaras MM; Lew S; Tepper R; Beyth Y; Ben-Baruch G
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):443-7. PubMed ID: 7835785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postmenopausal malignant transformation of extragenital endometriosis. A case report].
    Fat BC; Terzibachian JJ; Govyadovskiy A; Grisey A
    Gynecol Obstet Fertil; 2008 Jan; 36(1):51-5. PubMed ID: 18178119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer: a case report.
    Okugawa K; Hirakawa T; Ogawa S; Kaku T; Nakano H
    Gynecol Oncol; 2002 Nov; 87(2):231-4. PubMed ID: 12477460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
    Joja I; Asakawa T; Ando Y; Shiraiwa M; Shibutani O; Akaki S; Kuroda M; Mizutani Y; Kudo T; Hiraki Y
    Radiat Med; 1998; 16(4):315-9. PubMed ID: 9814431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause.
    Wu CJ; Peng YJ; Yu MH; Chen CH
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):88-90. PubMed ID: 17389201
    [No Abstract]   [Full Text] [Related]  

  • 6. Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity?
    Cohen I; Beyth Y; Tepper R; Figer A; Shapira J; Cordoba M; Yigael D; Altaras MM
    Gynecol Oncol; 1995 Jul; 58(1):86-91. PubMed ID: 7789896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy.
    McCluggage WG; Bryson C; Lamki H; Boyle DD
    Int J Gynecol Pathol; 2000 Jul; 19(3):276-9. PubMed ID: 10907178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian tumors in postmenopausal breast cancer patients treated with tamoxifen.
    Cohen I; Beyth Y; Tepper R; Shapira J; Zalel Y; Figer A; Cordoba M; Yigael D; Altaras MM
    Gynecol Oncol; 1996 Jan; 60(1):54-8. PubMed ID: 8557228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulosa cell tumor of the ovary associated with antecedent tamoxifen use.
    Gherman RB; Parker MF; Macri CI
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):717-9. PubMed ID: 9205462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endometriosis in tamoxifen therapy].
    Fuith LC; Pflanzl W
    Geburtshilfe Frauenheilkd; 1995 Jun; 55(6):354-5. PubMed ID: 7657147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virilizing ovarian tumor of low malignant potential associated with antecedent tamoxifen use for breast cancer.
    Surbek DV; Hoesli I; Torhorst J; Almendral AC; Dellas A; Holzgreve W
    Gynecol Oncol; 1998 Mar; 68(3):293-6. PubMed ID: 9570983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal and pelvic endometriosis presenting as a tumor and associated with tamoxifen therapy: report of a case.
    Hajjar LR; Kim W; Nolan GH; Turner S; Raju UR
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):642-4. PubMed ID: 8377997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
    Chew S; Tham KF; Ratnam SS
    Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post-menopausal endometriosis developed during tamoxifen treatment].
    Le Bouëdec G; Kauffmann P; Pingeon JM; de Latour M; Lemesle P; Dauplat J
    Rev Fr Gynecol Obstet; 1991 May; 86(5):407-10. PubMed ID: 1871504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis.
    Zanetta GM; Webb MJ; Li H; Keeney GL
    Gynecol Oncol; 2000 Oct; 79(1):18-22. PubMed ID: 11006024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral pelvic mass presenting in postmenopausal patients: report of two unusual cases.
    Hansen K; Simon RA; Lawrence WD; Quddus MR
    Ann Diagn Pathol; 2012 Aug; 16(4):298-301. PubMed ID: 21550273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenomatous polyp--cause of postmenopausal bleeding in a breast cancer patient treated with tamoxifen.
    Jahoorahmad PZ; Yatindra K; Jitendra VJ
    Singapore Med J; 2003 Jul; 44(7):359. PubMed ID: 14620729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrioid adenocarcinoma of the ovary and long-term tamoxifen therapy: a coincidence or a cause for concern?
    Kuo DY; Jones J; Fields AL; Runowicz CD; Goldberg GL
    Eur J Gynaecol Oncol; 1997; 18(6):457-60. PubMed ID: 9443009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and risk of epithelial ovarian cancer.
    Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
    Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.